Iatrica Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Iatrica General Information

Description

Developer of immunoconjugates for cancer therapy.The company operates as a biotechnology company which develops immunoconjugates for the treatment of cancer and other infectious disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 855 North . Wolfe Street
  • Suite 613
  • Baltimore, MD 21205
  • United States
+1 (410) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Iatrica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Profitable
To view Iatrica’s complete valuation and funding history, request access »

Iatrica Executive Team (2)

Name Title Board Seat Contact Info
Rajani Ravi Ph.D Co-Founder
Atul Bedi MD Co-Founder & President
To view Iatrica’s complete executive team members history, request access »

Iatrica Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Iatrica Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0
To view Iatrica’s complete investors history, request access »